Myovant, Pfizer’s expansion bid for Myfembree hits a snag at the FDA
Myovant, Pfizer’s expansion bid for Myfembree hits a snag at [...]
Myovant, Pfizer’s expansion bid for Myfembree hits a snag at [...]
Novartis’ global revamp to cost thousands of jobs for simpler [...]
High-flying Pfizer may disappoint on Comirnaty and Paxlovid sales in [...]
AACR: 2 years in, Amgen fortifies Lumakras lung cancer data [...]
Fierce Pharma Asia—Legend CSO’s departure; Takeda’s gene therapy deal; Pfizer’s [...]
Vertex CEO Kewalramani nabs more than $15M in 2021 pay, [...]
NICE tells Gilead to cut Trodelvy’s price and rejects eczema [...]
J&J scores one-two royalty punch against Genmab in blockbuster Darzalex [...]
Biogen’s troubled Aduhelm hit with CMS slapdown—now what? aliu Fri, [...]
AbbVie’s Rinvoq rockets up the pharma TV ad chart in [...]